TAPTIQOM

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, Germany, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug TAPTIQOM contains a combination of these active pharmaceutical ingredients (APIs):

1	Tafluprost UNII 1O6WQ6T7G3 - TAFLUPROST
	Tafluprost is a fluorinated analogue of prostaglandin F2α. Tafluprost acid, the biologically active metabolite of tafluprost, is a highly potent and selective agonist of the human prostanoid FP receptor.
	Read more about Tafluprost
2	Timolol UNII P8Y54F701R - TIMOLOL MALEATE
	Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.
	Read more about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	15319440, 15483346
EE	Ravimiamet	1618141, 1618152, 1792256, 1792267, 1792278, 1792289
ES	Centro de información online de medicamentos de la AEMPS	80037
FI	Lääkealan turvallisuus- ja kehittämiskeskus	040895, 388898, 581417
GB	Medicines & Healthcare Products Regulatory Agency	298871
HR	Agencija za lijekove i medicinske proizvode	HR-H-552420076, HR-H-889782438
IE	Health Products Regulatory Authority	36911
LT	Valstybinė vaistų kontrolės tarnyba	1070418, 1074957, 1091167, 1091168, 1091169, 1091170
MT	Medicines Authority	MA1068/00102
NL	Z-Index G-Standaard, PRK	128309
PL	Rejestru Produktów Leczniczych	100328789, 100420006
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68546001, W68546002